Abstract:
To demonstrate the effect of depot
medroxyprogesterone acetate (DMPA) and norethisterone
oenanthate (NET EN) on basal prolactin levels with a view to
investigating the role of progestogen-induced
hyperprolactinaemia in the pathogenesis of galactorrhoea,
amenorrhoea and possibly prolactinomas.